Home/Filings/4/0001737329-25-000004
4//SEC Filing

Iannone Robert 4

Accession 0001737329-25-000004

CIK 0001232524other

Filed

Nov 18, 7:00 PM ET

Accepted

Nov 19, 8:31 PM ET

Size

5.1 KB

Accession

0001737329-25-000004

Insider Transaction Report

Form 4
Period: 2025-11-17
Iannone Robert
EVP, Global Head of R&D & CMO
Transactions
  • Sale

    Ordinary Shares

    2025-11-17$168.26/sh7,159$1,204,57372,628 total
Footnotes (2)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
  • [F2]The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.

Issuer

Jazz Pharmaceuticals plc

CIK 0001232524

Entity typeother

Related Parties

1
  • filerCIK 0001737329

Filing Metadata

Form type
4
Filed
Nov 18, 7:00 PM ET
Accepted
Nov 19, 8:31 PM ET
Size
5.1 KB